Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluoxetine for Smoking Cessation in Smokers With Depressive Symptoms
NCT00578669Phase 3Completed
- Sponsor
- Butler Hospital
- Start
- Apr 2008
- Primary completion
- Jul 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of fluoxetine in nicotine dependence, sponsored by Butler Hospital. Primary endpoint: Smoking Abstinence at 1 year. Started Apr 2008; status: completed.
02
Drugs
fluoxetine
03
Conditions
nicotine dependence
Beyond the preview
Go deeper on NCT00578669.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00578669.